UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057024
Receipt number R000065146
Scientific Title Evaluation of the effect of remimazolam on A-delta fiber-selective nociceptive evoked potentials.
Date of disclosure of the study information 2025/02/17
Last modified on 2025/02/13 23:11:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the effect of remimazolam on A-delta fiber-selective nociceptive evoked potentials.

Acronym

Evaluation of the effect of remimazolam on A-delta fiber-selective nociceptive evoked potentials.

Scientific Title

Evaluation of the effect of remimazolam on A-delta fiber-selective nociceptive evoked potentials.

Scientific Title:Acronym

Evaluation of the effect of remimazolam on A-delta fiber-selective nociceptive evoked potentials.

Region

Japan


Condition

Condition

Patients undergoing general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of remimazolam on evoked potentials by measuring A-delta fiber-selective nociceptive evoked potentials using an intraepidermal stimulating electrode and comparing evoked potential amplitudes before and after remimazolam use.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amplitude of nociceptive evoked potentials

Key secondary outcomes

Latency of nociceptive evoked potentials, NRS, BIS index, MOAA/S


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Using a simulation model, set the continuous intravenous infusion rate so that the effect site concentration from continuous intravenous remimazolam infusion is (1) 0.2 micro g/ml and (2) 0.5 micro g/ml according to the age, height, and weight of the patient. The induction dose of remimazolam in the package insert should not exceed 12 mg/kg/hour.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(i) Patients 20 years of age or older at the time of obtaining consent
(ii) Patients undergoing general anesthesia with remimazolam
(iii) Patients who have given a full explanation of their participation in this study and who have given written consent based on their own free will.

Key exclusion criteria

(1) Patients with ASA-PS of 3 or higher
(2) Patients undergoing surgery for malignant tumors, and patients for whom the site of electrode application is the surgical site
(3) Patients diagnosed with diabetes, dementia, or epilepsy
(4) Patients with a pacemaker, implantable cardioverter-defibrillator, or deep brain stimulator
(5) Patients with skin lesions or numbness at the electrode site
(6) Patients with communication difficulties (e.g., non-Japanese speakers, patients with mental retardation, patients with consciousness disorders)
(7) Pregnant patients
(8) Patients with allergy to remimazolam or other benzodiazepines
(9) Other patients who are judged by the investigator to be difficult to conduct the study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kunihiro
Middle name
Last name Mitsuzawa

Organization

Shinshu University School of Medicine

Division name

The Department of Anesthesiology and Resuscitology

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto City, Nagano

TEL

0263-37-2670

Email

mitsukuni@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Kunihiro
Middle name
Last name Mitsuzawa

Organization

Shinshu University School of Medicine

Division name

The Department of Anesthesiology and Resuscitology

Zip code

390-0807

Address

3-1-1 Asahi, Matsumoto City, Nagano

TEL

09088009282

Homepage URL


Email

mitsukuni@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University School of Medicine Ethics Committee for Research in Life Sciences and Medicine

Address

3-1-1 Asahi, Matsumoto City, Nagano

Tel

0263-37-2572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 01 Month 04 Day

Date of IRB


Anticipated trial start date

2025 Year 02 Month 17 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 02 Month 13 Day

Last modified on

2025 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065146